FLACU
Frazier Lifesciences Acquisition Corp
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Frazier Lifesciences Acquisition Corporation, sponsored by a Cayman Islands affiliate of Frazier Life Sciences X, L.P., is a newly incorporated blank check company, incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. Frazier Lifesciences Acquisition Corporation expects that its focus will be on the biotechnology sector in developed countries including, but not limited to, the United States and countries in Europe.
Market Cap: 139 Million
Primary Exchange: NASDAQ
Website: frazierlifesciencesacquisition.com
Shares Outstanding: 7.63 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector:
Industry:
Ethical Flags
Longest drawdown: 627 trading days
From: 2021-02-12 To: 2022-11-22
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|